World

Norway raises worry over COVID-19 vaccine as 29 older people die after vaccination

Summary

Norway expressed rising concern about the Pfizer Inc. vaccine’s safety in older adults with significant underlying health problems after an estimate of 29 deaths after inoculation was raised. The new statistic adds six to Norway’s number of confirmed deaths and […]

Norway raises worry over COVID-19 vaccine as 29 older people die after vaccination
Norway raises worry over COVID-19 vaccine as 29 older people die after vaccination

Norway expressed rising concern about the Pfizer Inc. vaccine’s safety in older adults with significant underlying health problems after an estimate of 29 deaths after inoculation was raised.

The new statistic adds six to Norway’s number of confirmed deaths and limits the age group estimated to be affected to 75 from 80.

Although it is unknown precisely when the incidents happened, Norway has given about 42,000 people at least one dose and centered on those presumed most at risk if they, including the elderly, contract the virus.

Until Friday, January 15, 2021, the vaccine developed by Pfizer and BioNTech SE was the only one accessible in Norway, and the Norwegian Medicines Agency claimed in a written response to Bloomberg on Saturday, January 16, 2021, that “all deaths are therefore due to this vaccine.”

READ MORE:  USU Teams up with NICE inContact as a DEVone Partner for Knowledge Management

The agency said, “There are 13 deaths that have been evaluated, so we are aware of another 16 deaths that are currently being monitored.”

Most people have experienced the predicted side effects of the vaccine, such as nausea and vomiting, fever, local injection site reactions, and worsening of the underlying condition,” it said that; all the recorded deaths related to “old people with extreme basic ailments.

There have been rare official reports of allergic reactions as governments hurry to carry out vaccines to attempt to stop the global pandemic.

U.S. authorities confirmed twenty-one cases of serious allergic reactions from Dec. 14-23 after around 1.9 million initial doses of the Pfizer vaccine were administered.

READ MORE:  Panasonic doubles down with latest generation TOUGHBOOK 33 detachable notebook

At the end of January, the first Europe-wide safety study on the Pfizer-BioNTech vaccine is expected to be released.

Credits to Author:

Zoya_Hassan123 Fiverr

Leave a Reply

Your email address will not be published. Required fields are marked *